In addition, UCB has recently gained approval for certolizumab pegol (Cimzia) for the treatment ... First, abatacept has a short infusion time (30 minutes, compared with more than 2 hours for ...

If you want real strenght in plastics, though, or to produce a LOT of parts, you probably want to step up to injection molding. As it turns out, 3D printing can help in that regard, with injection ...

Raised full year 2025 guidance: Portfolio Receipts expected to be $2,975 to $3,125 million NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial ...

Based on strong response to our acquisition of all rights to the proposed biosimilar to Cimzia and to the broadening of our development pipeline, we are increasing full year guidance, to $600-$700 ...

Royalty Pharma reports Q1 2025 financials with 17% portfolio receipts growth, raising 2025 guidance to $2,975-$3,125 million. Royalty Pharma plc announced its financial results for the first ...

We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Alvotech (NASDAQ:ALVO) stands against the other ...

It also calls for safe injection sites, where individuals use drugs in the presence of a medical professional who can intervene in the case of an overdose. 5 EYEWITNESS NEWS reported in January ...

TEV-‘749 In January 2025, Teva announced that TEV-’749 (olanzapine LAI) achieved Phase 3 targeted injections without PDSS (post-injection delirium/sedation syndrome), and the full safety ...

We recently compiled a list of the 11 Stocks That Will Bounce Back According To Analysts. In this article, we are going to take a look at where Alvotech (NASDAQ:ALVO) stands against the other stocks ...

Based on strong response to our acquisition of all rights to the proposed biosimilar to Cimzia and to the broadening of our development pipeline, we are increasing full year guidance, to $600-$700 ...

Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments. The S&P 500 rose by 0.43% ...